Urinary Microbiome as a Biomarker for Melanoma Diagnosis and Response Prediction to Systemic Tumour Therapy
NCT07635732
·
clinicaltrials.gov ↗
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Melanoma Stage IV
Sponsor
Medical University of Graz